meloxicam 20 MG / rizatriptan 10 MG Oral Tablet [Symbravo]
- RxCUI
- 2711795
- RxNorm name
- meloxicam 20 MG / rizatriptan 10 MG Oral Tablet [Symbravo]
- Display name
- meloxicam 20 MG / rizatriptan 10 MG Oral Tablet [Symbravo]
- Full name
- meloxicam 20 MG / rizatriptan 10 MG Oral Tablet [Symbravo]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SYMBRAVO | MELOXICAM, RIZATRIPTAN | Axsome Therapeutics, Inc. | dcf1ecd1-08a0-8e47-e053-2a95a90abdc7 | 2025-11-21 | Boxed warning, Warnings, Adverse reactions | 2711795 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| dcf1ecd1-08a0-8e47-e053-2a95a90abdc7 | SYMBRAVO 20 MG / 10 MG Oral Tablet [PSN] · meloxicam 20 MG / rizatriptan 10 MG Oral Tablet [Symbravo] [SBD] · Symbravo (meloxicam 20 MG / rizatriptan 10 MG) Oral Tablet [SY] | 3 | 5 | These highlights do not include all the information needed to use SYMBRAVO safely and effectively. See full prescribing information for SYMBRAVO. SYMBRAVO (meloxicam and rizatriptan) tablets, for oral use Initial U.S. Approval: 2025 | 20251121 |